Encompass Health Opens First Connecticut Rehab Hospital in Danbury

Encompass Health Corporation (EHC) has expanded its national footprint by opening its 170th inpatient rehabilitation hospital in Danbury, CT, its first in the state, to address increasing demand for rehab care driven by an aging U.S. population. This strategic expansion aligns with EHC's strong financial performance, reporting net operating revenues up 11.3% year-over-year to $2.91 billion in the first half of 2025 and average occupancy rates rising to 77.7% in the same period. The company projects 2025 net operating revenues between $5.88-$5.98 billion and plans significant further de novo hospital and bed additions, contributing to its 36% year-to-date share price gain, outperforming the industry.

Analysis

Encompass Health Corporation (EHC) is executing a clear growth strategy centered on expanding its national footprint to capitalize on favorable demographic trends. The recent opening of its 170th hospital, the first in Connecticut, directly addresses the rising demand for rehabilitation services driven by an aging U.S. population and the increasing prevalence of chronic health conditions. This physical expansion is underpinned by robust financial and operational performance. The company reported an 11.3% year-over-year increase in net operating revenues to $2.91 billion for the first half of 2025, demonstrating strong top-line momentum. Operationally, EHC is showing increased efficiency and demand absorption, with average occupancy rates climbing steadily from 72.1% in 2023 to 77.7% in the first half of 2025. The company's forward guidance, projecting 2025 net operating revenues between $5.88 billion and $5.98 billion, is supported by an aggressive pipeline that includes seven new hospitals and 100-120 bed additions in existing facilities. The market has responded favorably to this strategy, with EHC's stock gaining 36% year-to-date, significantly outperforming the broader industry's 10.6% growth and reflecting investor confidence in its expansion and execution.

Key Decisions for Investors

• The combination of strong revenue growth, rising occupancy rates, and a clear expansion pipeline supports a continued constructive view on EHC, as the company appears well-positioned to capitalize on durable long-term demand for rehabilitation care.
• Investors should closely monitor the execution of the 2025 growth plan, particularly the successful launch of the seven de novo hospitals and whether occupancy rates are maintained or enhanced as significant new capacity comes online.
• Given the stock's substantial 36% year-to-date outperformance against its industry, investors should assess the current valuation for new entry points and consider whether the positive fundamental outlook is already priced in.